Cell cycle progression is a tightly controlled process. To initiate cell division, mitogens trigger a number of early signals that promote the G 0 -G 1 transition by inducing cell growth and the activation of G 1 cyclins. Activation of cyclin E/cdk2 (cyclin-dependent kinase 2) at the end of G 1 is then required to trigger DNA synthesis (S phase entry). Among the early signals induced by mitogens, activation of PI3K (phosphoinositide 3-kinase) appears essential to induce cell cycle entry, as it regulates cell growth signalling pathways, which in turn determine the rate of cell cycle progression. Another mechanisms by which PI3K and its downstream effector protein kinase B regulate cell cycle entry is by inactivation of the FOXO (Forkhead Box, subgroup O) transcription factors, which induce expression of quiescence genes such as those encoding p27 kip , p130 and cyclin G2. PI3K/FOXO then work as a complementary switch: when PI3K is active, FOXO transcription factors are inactive. The switch is turned on and off at different phases of the cell cycle, thus regulating cell cycle progression.
Cell division is the process by which a cell duplicates its DNA content and cell mass to generate two daughter cells. In mammals, this response is essential during embryonic development, and in the adult for tissue repair and renewal. Nonetheless, alterations in this process give rise to numerous diseases, among them the different forms of cancer.
The class I PI3Ks (phosphoinositide 3-kinases) are enzymes that catalyse the formation of PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 , which are present at low levels in quiescent cells, but are induced by growth factor receptor stimulation. Cellular PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 levels are also regulated by the phosphatase and tumour suppressor PTEN (phosphatase and tensin homologue deleted on chromosome 10). PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 induce the activation of several enzymes, such as PKB (protein kinase B), thereby regulating a variety of cell responses, including survival and division (reviewed in [1] [2] [3] ). Activation of PI3K/PKB controls cell cycle entry by inactivating the FOXO (Forkhead Box, subgroup O) family of Forkhead TFs (transcription factors), and by regulation of cyclin D and E levels [4] [5] [6] . Although cell division requires activation of different signalling cascades, the dramatic oncogenic potential of mutations that affect the PI3K pathway [1, 4] anticipate a crucial role for PI3K in the control of cell division.
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the G 0 -G 1 transition, which decreased 2-3 h after G 1 entry; a second, minor peak was observed in late G 1 [7, 8] , but PI3K/PKB activity was undetectable afterwards. FOXO showed complementary kinetics, as it was active in G 0 phase, inactive in G 1 and showed a second activity peak in G 2 . A genetic approach was taken to evaluate the consequences of altering these profiles. Expression of PI3K forms that modify the magnitude of PI3K activation resulted in a proportional alteration of G 1 -S and S-G 2 /M transition rates, supporting a critical role for PI3K activation in determining the cell cycle entry rate [7] . In addition, expression of a mutant exhibiting sustained PI3K activity impaired cell cycle exit, as it inhibited FOXO TF activation in G 2 , which is essential for induction of cyclin B and Polo-like kinase expression [7] . Inactivation of PI3K in G 2 phase and re-activation of FOXO TFs is thus essential for cell cycle termination.
In addition to its role in cell cycle termination, it has been shown that FOXO TF inactivation is essential for cell cycle entry [6] . The FOXO TF may control quiescence by regulating p27 kip and p130 expression [6, 9] . The role of p130 in quiescence is nonetheless unclear [10] , and p27 kip , a cyclin E/cdk2 (cyclin-dependent kinase 2) inhibitor, inhibits the G 1 -S transition rather than cell cycle entry (G 0 -G 1 transition) [11] . Based on the observation that PI3K activation reduces cyclin G2 expression, we studied the possible regulation of cyclin G2 by PI3K/FOXO TF. Cyclin G2 is an atypical cyclin that blocks cell cycle progression when overexpressed [12] , fluctuates during the cell cycle in lymphocytes [13] and is highly expressed in terminally differentiated cells [13] . We found that cyclin G2 expression also fluctuated during the cell cycle in fibroblasts; expression of an active FOXO TF increased the low cyclin G2 mRNA levels that were detected in G 1 , whereas interference with endogenous FOXO TF activity by expression of an inactive form reduced the high cyclin G2 expression levels in quiescent G 0 cells. The cyclin G2 promoter contains clustered FOXO TF consensus motifs that were found to bind and to be transactivated by FOXO TF [14] . These observations support the hypothesis that FOXO TF controls quiescence by regulating the expression of cyclin G2, a gene that is down-regulated following PI3K activation in G 1 . Inactivation of PI3K in G 0 and activation of FOXO TF are thus essential for controlling expression of the cell cycle inhibitor cyclin G2.
As mentioned above, PI3K and/or FOXO regulate the expression of cyclins D, E, B and G2 [4, 5, 7] . Cyclins are important for regulating cdks and thus promoting cell cycle progression [11] . Nonetheless, initiation of cell division also requires an increase in cell mass, although it is currently unclear how cyclin/cdk-mediated cell cycle entry and cell growth are co-ordinated during cell division (reviewed in [15] ). Signalling pathways that control the increase in cell mass, referred to as cell growth, have recently been elucidated. They include proteins such as p70 S6 kinase, mTOR (mammalian target of rapamycin), and the tuberous sclerosis complex, all of which are influenced by PI3K activity [15] . Based on the ability of PI3K to regulate pathways that control cell growth and cell cycle entry, we hypothesized that activation of PI3K may contribute to the concerted regulation of these processes during cell division in mammals. In fact, expression of mutants that increase or reduce the magnitude of transient PI3K activation affect proportionally the rate of protein synthesis of cycling cells. This alteration in cell growth is related to cell cycle progression rates, as it does not induce changes in cell size, but modifies the cell division time [16] . The key role of PI3K in growth control is supported by the observation that expression of a deregulated, constitutively active PI3K form altered p70 S6 kinase and mTOR activation kinetics, giving rise to larger cells [16] The magnitude of transient PI3K activation thus appears to co-ordinate cell growth and cell cycle progression rates.
Together, these observations support complementary PI3K/FOXO TF function in control of the cell cycle. When the PI3K switch is 'off' in G 0 , the FOXO TFs are active and regulate the expression of genes essential for quiescence maintenance, such as p27 kip , p130 and cyclin G2. At the G 0 -G 1 interphase, PI3K/PKB is turned on and adjusts cell growth, the magnitude of which in turn determines cell cycle entry rates, possibly through regulation of cyclin D and E levels. In addition, turning on the PI3K switch in early G 1 results in FOXO TF inactivation, which reduces the expression of genes that maintain quiescence (see above). Later in the cell cycle (in G 2 ), the PI3K switch is turned off and FOXO TFs are again activated and regulate cell cycle termination.
